Descrizione business
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research, and advanced cell therapies for the industry's top pharmaceutical, biotech, academic, and healthcare institutions globally.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Stephen S. Schwartz |
| Consiglio di amministrazione |
| Herman Cueto, Jason W. Joseph, John O'Brien, Michael Paulo, Olga Pirogova, Luc Provost, Robin Vacha, David Wang, Rob Woodward, Ginger Zhou |
| Consiglio di sorveglianza |
| Frank E. Casal, Edward P. Bousa, Robyn C. Davis, Didier Hirsch, Martin D. Madaus, Erica J. McLaughlin, Tina S. Nova, Michael Rosenblatt |
Dati aziendali
| Name: |
Azenta Inc |
| Indirizzo: |
200 Summit Drive 6th Floor,Burlington, Massachusetts 01803 |
| Telefono: |
+1-978-262-2626 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.azenta.com/ |
| Industria: |
Healthcare |
| Settore: |
Medical Products |
| Sub settore: |
Medical Supplies |
| Fine dell'anno finanziario: |
30/09 |
| Flottante libero: |
- |
| Data dell'IPO: |
- |
Rapporti con gli investitori
| Name: |
Sara Silverman |
| IR telefono: |
+1-877-373-6374 |
| IR Fax: |
- |
| IR e-mail: |
ir@azenta.com
|
